Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report

Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patie...

Full description

Saved in:
Bibliographic Details
Main Authors: Christie Walker, Shawky Z. A. Badawy
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2013/835316
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547420122120192
author Christie Walker
Shawky Z. A. Badawy
author_facet Christie Walker
Shawky Z. A. Badawy
author_sort Christie Walker
collection DOAJ
description Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patient that was very symptomatic with regard to vaginal atrophic changes determined by vaginal cytology. This side effect may become increasingly more common as we see more long-term use of DMPA.
format Article
id doaj-art-305b9abe2dcd4d9f8caf735f6153cbb6
institution Kabale University
issn 2090-6684
2090-6692
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Obstetrics and Gynecology
spelling doaj-art-305b9abe2dcd4d9f8caf735f6153cbb62025-02-03T06:44:43ZengWileyCase Reports in Obstetrics and Gynecology2090-66842090-66922013-01-01201310.1155/2013/835316835316Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case ReportChristie Walker0Shawky Z. A. Badawy1Department of Obstetrics and Gynecology, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USADepartment of Obstetrics and Gynecology, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USADepot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user. The mode of action is through the suppression of ovulation. It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia. We present in this paper a patient that was very symptomatic with regard to vaginal atrophic changes determined by vaginal cytology. This side effect may become increasingly more common as we see more long-term use of DMPA.http://dx.doi.org/10.1155/2013/835316
spellingShingle Christie Walker
Shawky Z. A. Badawy
Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
Case Reports in Obstetrics and Gynecology
title Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_full Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_fullStr Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_full_unstemmed Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_short Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use: A Case Report
title_sort vaginal atrophy following long term depot medroxyprogesterone acetate use a case report
url http://dx.doi.org/10.1155/2013/835316
work_keys_str_mv AT christiewalker vaginalatrophyfollowinglongtermdepotmedroxyprogesteroneacetateuseacasereport
AT shawkyzabadawy vaginalatrophyfollowinglongtermdepotmedroxyprogesteroneacetateuseacasereport